Danaher Corporation $DHR Position Increased by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. raised its position in Danaher Corporation (NYSE:DHR) by 16.8% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 284,412 shares of the conglomerate’s stock after acquiring an additional 41,003 shares during the quarter. Eurizon Capital SGR S.p.A.’s holdings in Danaher were worth $63,120,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in DHR. Gunderson Capital Management LLC purchased a new stake in shares of Danaher in the 3rd quarter worth $765,000. EP Wealth Advisors LLC purchased a new position in Danaher during the second quarter valued at $3,807,000. Frank Rimerman Advisors LLC grew its holdings in Danaher by 181.9% during the third quarter. Frank Rimerman Advisors LLC now owns 40,855 shares of the conglomerate’s stock valued at $9,051,000 after purchasing an additional 26,363 shares during the period. Birch Hill Investment Advisors LLC grew its holdings in Danaher by 9.6% during the third quarter. Birch Hill Investment Advisors LLC now owns 40,549 shares of the conglomerate’s stock valued at $8,984,000 after purchasing an additional 3,553 shares during the period. Finally, Forbes J M & Co. LLP grew its holdings in Danaher by 141.6% during the third quarter. Forbes J M & Co. LLP now owns 4,276 shares of the conglomerate’s stock valued at $947,000 after purchasing an additional 2,506 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Insider Activity at Danaher

In other Danaher news, CAO Christopher Bouda sold 7,598 shares of the company’s stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the transaction, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. This represents a 45.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Gregory M. Milosevich sold 2,100 shares of the stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $230.62, for a total transaction of $484,302.00. Following the sale, the executive vice president directly owned 22,367 shares of the company’s stock, valued at approximately $5,158,277.54. This trade represents a 8.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 10.80% of the stock is currently owned by company insiders.

Danaher Trading Down 1.4%

Shares of DHR stock opened at $232.08 on Friday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The firm has a market capitalization of $163.28 billion, a PE ratio of 37.98, a PEG ratio of 2.95 and a beta of 0.76. The stock has a fifty day simple moving average of $222.11 and a two-hundred day simple moving average of $201.53.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The business had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. During the same period in the previous year, the business earned $1.89 earnings per share. The business’s revenue was up 8.3% on a year-over-year basis. On average, analysts predict that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is 26.19%.

Analyst Ratings Changes

Several research analysts have recently commented on the company. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $275.00 price objective on shares of Danaher in a research note on Thursday, October 22nd. Robert W. Baird boosted their price objective on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a research note on Thursday, October 22nd. Weiss Ratings upgraded Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, September 16th. Citigroup increased their target price on shares of Danaher from $230.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Finally, DZ Bank cut shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $242.91.

Danaher Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.